Accuracy of exhaled nitric oxide measurements for the diagnosis of bronchiolitis obliterans syndrome after lung transplantation

Transplantation

Volumn 78, Issue 5, 2004, Pages 730-733

  Verleden, Geert M ^a   Dupont, Lieven J ^a   Van Raemdonck, Dirk E ^a   Vanhaecke, Johan ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

BOS; Chronic rejection; Exhaled NO; Lung transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NITRIC OXIDE; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; BRONCHIOLITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY DIAGNOSIS; LUNG TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SPIROMETRY;

ADULT; BREATH TESTS; BRONCHIOLITIS OBLITERANS; FEMALE; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; NITRIC OXIDE; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 4544313875     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000131814.44106.C0     Document Type: Article

References (24)

1. Van den Berg JW, Geertsma A, van der Bij W, et al. Bronchiolitis obliterans syndrome after lung transplantation and health-related quality of life. Am J Respir Crit Care Med 2000; 161: 1937.
2. Trulock EP, Edwards LB, Taylor DO, et al. The Registry of the International Society for Heart and Lung Transplantation: twentieth official adult heart-lung report, 2003. J Heart Lung Transplant 2003; 22: 625.
3. Valentine VG, Robbins RC, Berry GJ, et al. Actuarial survival of heart-lung and bilateral lung transplant recipients with obliterative bronchiolitis. J Heart Lung Transplant 1996; 15: 371.
4. Reichenspurner H, Girgis RE, Robbins RC, et al. Obliterative bronchiolitis after lung and heart-lung transplantation. Ann Thorac Surg 1995; 60: 1845.
5. Fisher AJ, Gabbay E, Small T, et al. Cross sectional study of exhaled nitric oxide levels following lung transplantation. Thorax 1998; 53: 454.
6. Verleden GM, Dupont LJ, Lamont J, et al. Is there a role for measuring exhaled nitric oxide in lung transplant recipients with chronic rejection [Letter to the Editor]? J Heart Lung Transplant 1998; 17: 231.
7. Gabbay E, Walters EH, Orsida B, et al. Post-lung transplant bronchiolitis obliterans syndrome is characterized by increased exhaled nitric oxide levels and epithelial inducible nitric oxide synthase. Am J Respir Crit Care Med 2000; 162: 2182.
8. Verleden GM, Dupont LJ, Delcroix M, et al. Exhaled nitric oxide after lung transplantation: impact of the native lung. Eur Respir J 2003; 21: 429.
9. Verleden GM, Dupont LJ, Van Raemdonck D, et al. The effect of switching cydosporine A to tacrolimus on exhaled nitric oxide and pulmonary function in patients with chronic rejection after lung transplantation. J Heart Lung Transplant 2003; 22: 908.
10. Estenne M, Maurer J, Boehler A, et al. Bronchiolitis obliterans syndrome: an update of the diagnostic criteria. J Heart Lung Transplant 2002; 21: 297.
11. Kharitonov SA, Alving K, Barnes PJ. Exhaled and nasal nitric oxide measurements: recommendations. Eur Respir J 1997; 10: 1683.
12. Persson M, Zetterstrom O, Agrenius V, et al. Single-breath nitric oxide measurements in asthmatic patients and smokers. Lancet 1994; 343: 146.
13. Dupont LJ, Rochette F, Demedts MG, et al. Exhaled nitric oxide correlates with airway hyperresponsiveness in steroid-naive asthmatic patients. Am J Respir Crit Care Med 1998; 157: 894.
14. Kharitonov SA, Wells AU, O'Connor BJ, et al. Elevated levels of exhaled nitric oxide in bronchiectasis. Am J Respir Crit Care Med 1995; 151: 1898.
15. Kharitonov SA, Yates D, Barnes PJ. Increased nitric oxide in exhaled air of normal human subjects with upper respiratory tract infection. Eur Respir J 1995; 8: 295.
16. Koek GH, Verleden GM, Evenepoel P, et al. Activity related increase of exhaled nitric oxide in Crohn's diseases and ulcerative colitis: a manifestation of systemic involvement? Respir Med 2002; 96: 530.
17. Kharitonov SA, Yates DH, Barnes PJ. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med 1996; 153: 454.
18. Husain AN, Siddiqui MT, Holmes EW, et al. Analysis of risk factors for the development of bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 1999; 159: 829.
19. De Soyza A, Fisher AJ, Small T, et al. Inhaled corticosteroids and the treatment of lymphocytic bronchiolitis following lung transplantation. Am J Respir Crit Care Med 2001; 164: 1209.
20. Nathan SD, Barnett SD, Wohlrab J, et al. Bronchiolitis obliterans syndrome: utility of the new guidelines in single lung recipients. J Heart Lung Transplant 2003; 22: 427.
21. Patterson GM, Wilson S, Whang JH, et al. Physiologic definitions of obliterative bronchiolitis in heart-lung and double lung transplantation: a comparison of the forced expiratory volume between 25% and 75% of the forced vital capacity and forced expiratory volume in one second. J Heart Lung Transplant 1996; 15: 175.
22. Estenne M, Van Muylem A, Knoop C, et al. Detection of obliterative bronchiolitis after lung transplantation by indexes of ventilation distribution. Am J Respir Crit Care Med. 2000; 162: 1047.
23. Reynaud-Gaubert M, Thomas P, Badier M, et al. Early detection of airway involvement in obliterative bronchiolitis after lung transplantation. Functional and bronchoalveolar lavage cell findings. Am J Respir Crit Care Med 2000; 161: 1924.
24. Hachem RA, Chakinala MM, Yusen RD, et al. The predictive value of bronchiolitis obliterans syndrome stage 0-p. Am J Respir Crit Care Med 2004; 169: 468.